PAHC
Phibro Animal Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Buy"
Ample Liquidity
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PAHC
Phibro Animal Health Corporation
A leading global diversified animal health and mineral nutrition company
Healthcare Providers and Services
--
04/11/2014
NASDAQ Stock Exchange
2,475
06-30
Common stock
Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Boulevard, Suite 21, Teaneck, New Jersey 07666-6712
--
Phibro Animal Health Corporation is a Delaware corporation. The company is the world's leading diversified animal health and mineral nutrition company. The company is committed to being a trusted partner for livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals, providing them with solutions to help them maintain and improve animal health. The company develops, manufactures and markets a wide range of food and companion animal products, including poultry, pigs, cattle and dairy cows, aquaculture and dogs. The company's products help prevent, control and treat disease and support nutrition to help improve animal health and well-being. The company sells animal health and mineral nutrition products directly to integrated poultry, pig and cattle producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.
Earnings Call
Q3/2025
Estimate EPS0.52
Actual EPS0.63
Estimate Revenue352.41M
Actual Revenue347.80M
Phibro Animal Health's Q3 2025: Navigating Contradictions in Tariffs, MFA Performance, and Strategic Initiatives
May 19,2025 07:32
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
PAHC has released its 2026 Q1 earnings. EPS was reported at 0.73, versus the expected 0.6, beating expectations. The chart below visualizes how PAHC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PAHC has released its 2026 Q1 earnings report, with revenue of 363.89M, reflecting a YoY change of 39.73%, and net profit of 26.53M, showing a YoY change of 280.32%. The Sankey diagram below clearly presents PAHC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
